Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASH study in aneurysmal subarachnoid hemorrhage
NL-OMON20670Recruiting
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in subarachnoid hemorrhage (SAH) comparing Magnesium sulfate with Placebo (2 arms). Primary endpoint: Poor outcome at 3 months. Started Jan 2006; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NL-OMON20670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20670.